会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • Use of an interleukin-6 molecule in inhibiting bone resorption
    • Verwendung eines Interleukin-6-Molekuls zur Verhinderung von Knochenresorption。
    • EP0331640A2
    • 1989-09-06
    • EP89810155.5
    • 1989-02-28
    • SANDOZ AG
    • Feyen, Jean Honoré M.Trechsel, Ulrich
    • A61K37/02
    • A61K38/204
    • We have found that IL-6 molecules are useful in inhibiting bone resorption and increasing bone formation. They are thus useful in treating osteoporosis, e.g. acute and/or chronic stages of postmenopausal osteoporosis, including primary and/or secondary osteoporosis and localized osteoporosis, posttraumatic osteoporosis, Paget's disease of bone (osteitis deformans), osteolysis due to bone malignancies, e.g. osteogenic sarcoma, osteodystrophy, e.g. renal osteodystrophy, osteomalacia, multiple myeloma of the bone, osteogenesis imperfecta, hypercalcemia, osteomyelitis, e.g. in conjunction with antibiotics and ectopic calcification.
    • 我们发现IL-6分子可用于抑制骨吸收和增加骨形成。 因此它们可用于治疗骨质疏松症,例如 绝经后骨质疏松症的急性和/或慢性阶段,包括原发性和/或继发性骨质疏松症和局部骨质疏松症,创伤后骨质疏松症,骨盆畸形骨畸形(骨折性变性骨质疏松症),由于骨恶性肿瘤引起的骨质疏松症。 成骨肉瘤,骨营养不良等。 肾性骨营养不良,骨软化,骨髓多发性骨髓瘤,成骨不全,高钙血症,骨髓炎等。 结合抗生素和异位钙化。